The purpose of this legislation, known as "Gwenn's Law," is to enhance the participation of women in clinical trials supported by the National Institutes of Health (NIH) and to improve awareness of bleeding and clotting disorders among women. The law aims to address the historical underrepresentation of women in medical research, which can lead to gaps in understanding how diseases and treatments affect them. Key provisions of the law include the establishment of a public awareness campaign by the Secretary of Health and Human Services.